| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.6M | +7.6% |
| Cost of Revenue | $32.6M | +5.2% |
| Gross Profit | $38.0M | +9.7% |
| R&D Expense | $8.5M | +17.7% |
| SG&A Expense | $10.4M | +11.0% |
| Operating Income | $19.1M | +5.8% |
| Pre-tax Income | $22.2M | +10.1% |
| Income Tax | $3.0M | +28.5% |
| Net Income | $19.2M | +7.7% |
| EPS (Basic) | $1.03 | +6.2% |
| EPS (Diluted) | $1.01 | +6.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.8M | +396.1% |
| Short-term Investments | $4.5M | -91.3% |
| Accounts Receivable | $487K | +1117.5% |
| Inventory | $14.2M | +49.6% |
| Current Assets | $88.4M | +16.4% |
| Total Assets | $95.6M | +14.1% |
| Current Liabilities | $11.5M | +8.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.7M | -32.5% |
| Capital Expenditures | $213K | -31.5% |
| Investing Cash Flow | $48.8M | +368.6% |
| Financing Cash Flow | -$9.3M | -1.0% |
| Free Cash Flow | $14.5M | -32.5% |
| Total Liabilities |
| $11.9M |
| +3.8% |
| Stockholders' Equity | $83.6M | +15.7% |